The European Central Bank announced that it would cut three key interest rates in the euro zone. On the 12th local time, the European Central Bank held a monetary policy meeting at its headquarters in Frankfurt, Germany, and decided to cut all three key interest rates by 25 basis points. This is also the fourth time that the European Central Bank cut interest rates this year after it announced a rate cut in June this year. According to the latest interest rate resolution announced by the European Central Bank, the deposit mechanism interest rate is reduced to 3.0%, the main refinancing interest rate is reduced to 3.15%, and the marginal lending interest rate is reduced to 3.40%. (CCTV News)The offshore RMB retreated against the US dollar, and now it is reported at 7.2700.Analyst: The interest rate of the European Central Bank will be pushed to the low end of the neutral range. Marchel Alexandrovich, an economist at Saltmarsh Economics, said that the European Central Bank cut interest rates by 25 basis points again, which is the fourth time in this easing cycle. The monetary policy statement reiterated that the Committee would not commit to a specific interest rate path in advance. However, the new forecast shows that the core inflation rate is 1.9% in 2026 and 2027, which indicates that interest rates may continue to push to the low end of the neutral range.
The Korea Composite Index closed up 1.60%.Anhui's first high-growth industrial bond was successfully issued in Shanghai. Recently, Anhui Wantong Expressway Co., Ltd. (referred to as "Wantong Expressway") completed the issuance of Anhui's first high-growth industrial bond in Shanghai Stock Exchange. On October 30th this year, Wan Tong Expressway was approved by China Securities Regulatory Commission to publicly issue corporate bonds with a registered scale of no more than 5 billion yuan to professional investors.The average annual salary of doctors is 690,000, and the fixed income accounts for 70%. On the afternoon of December 10th, National Health Commission held a press conference in Shenzhen around the promotion of Sanming's medical reform experience. Relevant officials in Guangdong, Guangzhou and Shenzhen introduced the local medical reform including centralized procurement, price adjustment and salary reform. In 2012, the Shenzhen Municipal People's Government fully invested in introducing the modern management mode of the University of Hong Kong and established the Shenzhen Hospital of the University of Hong Kong. From the details of space design and department name, we can feel that this hospital is different from ordinary mainland hospitals, and the difference in internal system may be even greater-the average annual salary of doctors in this hospital is 690,000 yuan, which is 4.8 times that of the local social wage, of which the fixed salary accounts for 70% and the performance appraisal is 30%. Generally speaking, performance income accounts for a large part of doctors' income. The reporter interviewed two doctors in tertiary hospitals in Beijing, and their performance pay accounted for about 60-70%, which was significantly higher than the fixed salary. In a set of internal data presented by Xu Xiaoping, secretary of the Party Committee of Shenzhen Hospital of the University of Hong Kong, the salary structure of three well-known 3A hospitals in Beijing, Sichuan and Zhejiang is listed, showing that the proportion of fixed income ranges from 20% to 47%. (Beijing News)
Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13